en
Scientific article
Letter
English

Abl inhibitor BMS354825 binding mode in Abelson kinase revealed by molecular docking studies

Published inLeukemia, vol. 19, no. 7, p. 1267-1269
Publication date2005-07
Keywords
  • Computer Simulation
  • Dasatinib
  • Models, Molecular
  • Protein Binding / drug effects
  • Protein Conformation
  • Protein Kinase Inhibitors / chemistry
  • Protein Kinase Inhibitors / pharmacology
  • Protein Structure, Tertiary
  • Protein-Tyrosine Kinases / antagonists & inhibitors
  • Protein-Tyrosine Kinases / chemistry
  • Proto-Oncogene Proteins c-abl / antagonists & inhibitors
  • Proto-Oncogene Proteins c-abl / chemistry
  • Pyrimidines / chemistry
  • Pyrimidines / pharmacology
  • Structure-Activity Relationship
  • Thiazoles / chemistry
  • Thiazoles / pharmacology
Citation (ISO format)
GAMBACORTI-PASSERINI, Carlo et al. Abl inhibitor BMS354825 binding mode in Abelson kinase revealed by molecular docking studies. In: Leukemia, 2005, vol. 19, n° 7, p. 1267–1269. doi: 10.1038/sj.leu.2403775
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal0887-6924
60views
0downloads

Technical informations

Creation01/13/2023 11:43:00 AM
First validation01/13/2023 11:43:00 AM
Update time03/16/2023 10:25:38 AM
Status update03/16/2023 10:25:38 AM
Last indexation01/17/2024 10:43:08 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack